APA (7th ed.) Citation

Luz, P., Lopes-Brás, R., de Pinho, I. S., Patel, V., Esperança-Martins, M., Gonçalves, L., . . . Fernandes, A. S. (2025). Predictive factors for pCR and relapse following neoadjuvant dual HER2-blockade in HER2+ breast cancer. Clinical and Translational Oncology, 1-10. https://doi.org/10.1007/s12094-025-03937-7

Chicago Style (17th ed.) Citation

Luz, Paulo, et al. "Predictive Factors for PCR and Relapse Following Neoadjuvant Dual HER2-blockade in HER2+ Breast Cancer." Clinical and Translational Oncology 2025: 1-10. https://doi.org/10.1007/s12094-025-03937-7.

MLA (9th ed.) Citation

Luz, Paulo, et al. "Predictive Factors for PCR and Relapse Following Neoadjuvant Dual HER2-blockade in HER2+ Breast Cancer." Clinical and Translational Oncology, 2025, pp. 1-10, https://doi.org/10.1007/s12094-025-03937-7.